CytomX Therapeutics Inc. (CTMX)
NASDAQ · Healthcare
CytomX Therapeutics Inc. Revenue 2013–2025
CytomX Therapeutics Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- CytomX Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 10.3 M, a 79.85% decrease year-over-year.
- CytomX Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 85.8 M, a 32.12% decrease year-over-year.
- CytomX Therapeutics Inc. annual revenue for 2025 was 76.2 M, a 44.82% decrease from 2024.
- CytomX Therapeutics Inc. annual revenue for 2024 was 138.1 M, a 36.45% increase from 2023.
- CytomX Therapeutics Inc. annual revenue for 2023 was 101.2 M, a 90.38% increase from 2022.
- CytomX Therapeutics Inc. annual revenue for 2022 was 53.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CytomX Therapeutics Inc. Revenue — FAQ
CytomX Therapeutics Inc. (CTMX) revenue over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is CytomX Therapeutics Inc.'s revenue?
CytomX Therapeutics Inc. (CTMX) reported revenue of $76M for fiscal 2025.
Where can I see CTMX's revenue history?
The chart and table above show CytomX Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.